The study is a monocentric, controlled randomized trial. Its an interventional method study. There is a control and an interventional group. The interventional group is receiving a specific inspiratory muscle training with "Respifit" (special device for inspiratory muscle training) during the first 30 days after allogenic stem cell transplantation. The investigators want to show that the training group gets stronger inspiratory muscles. The investigators measure the change of PIMAX values and MVV values.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
106
Inspiratory Muscle Training with Respifit (5 times per week)
Inspiratory muscle training with a device named Respifit for patients receiving a hematopoetic stem cell transplantation (till 30 days after their transplantation)
Elisabethinen Hospital
Linz, Austria
RECRUITINGChange of PI max-value from baseline at 30 days after stem cell transplantation
max strength of the inspiratory muscles
Time frame: baseline and 30 days after stem cell transplantation
Change of MVV-value from baseline at 30 days after transplantation
max voluntary volume for Inspiratory muscle endurance
Time frame: baseline and 30 days after stem cell transplantation
inpatient days
Time frame: from baseline to maximal 60 days after stem cell transplantation
Incidence of pneumonia
Time frame: from baseline to 30 days after stem cell transplantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.